June 7, 2007 — NASA space technology is helping doctors diagnose and monitor treatments for hardening of the arteries in ...
June 5, 2007 - Photon2 announced that it has received FDA approval for its new compact cardiac camera. The C! is a gamma camera designed for cardiologists in the diagnosis of cardiac disease.
June 5, 2007 — Men whose blood tests positive for the auto-antibody rheumatoid factor have a three times higher risk of ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 5, 2007 - Siemens Medical Solutions Molecular Imaging division demonstrated three new syngo software packages ...
June 4, 2007 — Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AspirinWorks Test Kit, the Company's newest diagnostic product.
June 5, 2007 - GE Healthcare introduced at SNM a new version of the company’s Discovery Dimension designed to help ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
June 5, 2007 - GVI Medical Devices, Inc., extended its nuclear cardiology line with the introduction of ClearVision ...
June 5, 2007 — A patch designed to help damaged cardiac tissue recover from a heart attack has been successful in early ...
June 4, 2007 — Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
June 4, 2007 — A new radiological test, used to detect acute coronary trauma has the ability to save valuable time and ...
June 4, 2007 — Biodegradable magnesium stents have been developed to treat blockages in coronary arteries. The stents will degrade within four months and achieve the same results as conventional stents, conclude authors of an article published in this week's edition of The Lancet.
June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 1, 2007 —ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, was ...
June 1, 2007 — Siemens recently announced the introduction of Syngo DynaCT Cardiac, which provides three-dimensional ...
June 1, 2007 — New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation ...
June 06, 2007
